Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Bisphosphonates: prevention of bone metastases in breast cancer.

Gnant M, Dubsky P, Hadji P.

Recent Results Cancer Res. 2012;192:65-91. doi: 10.1007/978-3-642-21892-7_3. Review.

PMID:
22307370
2.

Anticancer activity of bisphosphonates in breast cancer.

Gnant M.

Anticancer Agents Med Chem. 2012 Feb;12(2):114-22. Review.

PMID:
21864231
3.

Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.

Li J, Rugo HS.

Breast Dis. 2011;33(2):83-92. doi: 10.3233/BD-2010-0326. Review.

PMID:
22142661
4.

[The role of bisphosphonates of adjuvant therapy in breast cancer].

Gálvez-Muñoz E, Rodríguez-Lescure Á.

Med Clin (Barc). 2010 Jun 12;135(2):70-4. doi: 10.1016/j.medcli.2009.10.013. Review. Spanish.

PMID:
20022069
5.

Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature.

Gnant M, Clézardin P.

Cancer Treat Rev. 2012 Aug;38(5):407-15. doi: 10.1016/j.ctrv.2011.09.003. Epub 2011 Oct 7. Review.

PMID:
21983264
6.

Bisphosphonates and breast cancer incidence and recurrence.

Chlebowski RT, Col N.

Breast Dis. 2011;33(2):93-101. doi: 10.3233/BD-2010-0324. Review.

PMID:
22142660
7.

Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials.

Gnant M.

Curr Cancer Drug Targets. 2009 Nov;9(7):824-33. Review.

PMID:
20025570
8.

Prevention of bone metastases and management of bone health in early breast cancer.

Gnant M, Hadji P.

Breast Cancer Res. 2010;12(6):216. doi: 10.1186/bcr2768. Epub 2010 Dec 17. Review.

9.

Should bisphosphonates be utilized in the adjuvant setting for breast cancer?

Lipton A.

Breast Cancer Res Treat. 2010 Aug;122(3):627-36. doi: 10.1007/s10549-010-0935-7. Epub 2010 May 21. Review.

PMID:
20490653
10.

Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.

Gnant M.

Breast Dis. 2011;33(2):71-81. doi: 10.3233/BD-2010-0325. Review.

PMID:
22142663
11.

Bone-modifying agents as adjuvant therapy for early-stage breast cancer.

Figueroa-Magalhães MC, Miller RS.

Oncology (Williston Park). 2012 Oct;26(10):955-62. Review.

12.

Bisphosphonates as treatment of bone metastases.

Holen I, Coleman RE.

Curr Pharm Des. 2010;16(11):1262-71. Review.

PMID:
20166976
13.

New results from the use of bisphosphonates in cancer patients.

Coleman R, Gnant M.

Curr Opin Support Palliat Care. 2009 Sep;3(3):213-8. doi: 10.1097/SPC.0b013e32832f4149. Review.

PMID:
19561507
14.

Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?

Coleman RE.

Eur J Cancer. 2009 Jul;45(11):1909-15. doi: 10.1016/j.ejca.2009.04.022. Epub 2009 May 15.

PMID:
19447606
15.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
16.

Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.

Kremer R, Gagnon B, Meguerditchian AN, Nadeau L, Mayo N.

J Natl Cancer Inst. 2014 Oct 2;106(11). pii: dju264. doi: 10.1093/jnci/dju264. Print 2014 Nov.

PMID:
25278509
17.

Zoledronic acid use in cancer patients: more than just supportive care?

Coleman R, Cook R, Hirsh V, Major P, Lipton A.

Cancer. 2011 Jan 1;117(1):11-23. Review.

PMID:
21235033
18.

Potential use of bisphosphonates in the prevention of metastases in early-stage breast cancer.

Coleman R.

Clin Breast Cancer. 2007 Jul;7 Suppl 1:S29-35. Review.

PMID:
17683651
19.

The role of bisphosphonates in breast and prostate cancers.

Brown JE, Neville-Webbe H, Coleman RE.

Endocr Relat Cancer. 2004 Jun;11(2):207-24. Review.

20.

The endocrine influence on the bone microenvironment in early breast cancer.

Wilson C, Brown H, Holen I.

Endocr Relat Cancer. 2016 Dec;23(12):R567-R576. Epub 2016 Sep 29. Review.

Supplemental Content

Support Center